{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:30:37Z","timestamp":1789565437200,"version":"build-2803163510"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"35","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer\u2019s Institute of Translational Equitable Medicine"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>The objective of this study was to define the relationships between the circulating proteome and metabolome with cardiac structure and function in patients with breast cancer receiving cardiotoxic therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Proteomics and metabolomics profiling was performed in a longitudinal, prospective cohort study of breast cancer patients receiving anthracyclines and\/or trastuzumab, using the Olink Explore 3072 platform and rapid liquid chromatography-mass spectrometry, respectively. Multivariable linear mixed-effect models evaluated the contemporaneous (same visit) and lagged (subsequent visit) associations between repeated measures of individual proteins or metabolites with quantitative echocardiographic measures of cardiac structure [left ventricular (LV) mass and left atrial volume index] and function [LV ejection fraction (LVEF), longitudinal and circumferential strain, E\/e\u2032, and ventricular-arterial coupling]. Cox regression and pathway enrichment analyses were conducted for biomarkers demonstrating significant associations with cardiac function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across 547 breast cancer participants (median age 50 years), 203 unique proteins and 16 unique metabolites were significantly associated with measures of cardiac structure and function in contemporaneous and lagged analyses. Notably, cathepsin C was associated with LVEF [false discovery rate (FDR), P = .017], longitudinal strain (FDR, P = .046), left atrial volume index (FDR, P = .035), and incident cardiac dysfunction, defined by an LVEF decline \u226510% to &amp;lt;50% (hazard ratio .61, 95% confidence interval .41, .90). The 147 proteins associated with cardiac function were enriched in biological processes reflective of protein deubiquitination, protein modification by small protein removal, macromolecule catabolic processes, and global metabolic pathways. Individual metabolites significantly associated with cardiac function (LVEF, longitudinal strain) included n-acetylglutamine, aspartic acid, acetylasparagine, alanyl-alanine, and prolyl-glycine (FDR, P-value &amp;lt; .001), and belonged to amino acids and derivatives and peptides.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings provide translational insights into cancer therapy-related cardiac dysfunction and remodelling and identify potential new biomarkers of cardiotoxicity. There is an important need for validation of these findings and a deeper understanding of the biology of these biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag487","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:30:08Z","timestamp":1781004608000},"page":"5010-5025","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6628-9981","authenticated-orcid":false,"given":"Bonnie","family":"Ky","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]},{"name":"Thalheimer Center for Cardio-Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]},{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-5965","authenticated-orcid":false,"given":"Congying","family":"Xia","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]},{"name":"Thalheimer Center for Cardio-Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyunga","family":"Ko","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]},{"name":"Thalheimer Center for Cardio-Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Hyde","sequence":"additional","affiliation":[{"name":"Research and Development, Pfizer Inc , 1 Portland Street, Cambridge, MA 02139 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]},{"name":"Thalheimer Center for Cardio-Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7044-2985","authenticated-orcid":false,"given":"June-Wha","family":"Rhee","sequence":"additional","affiliation":[{"name":"City of Hope Comprehensive Cancer Center Division of Cardiology, Department of Medicine, , Duarte, CA 91010 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Tow-Keogh","sequence":"additional","affiliation":[{"name":"Research and Development, Pfizer Inc , 1 Portland Street, Cambridge, MA 02139 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Tierney","sequence":"additional","affiliation":[{"name":"Research and Development, Pfizer Inc , 1 Portland Street, Cambridge, MA 02139 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Long","sequence":"additional","affiliation":[{"name":"Sapient Bioanalytics LLC , San Diego, CA 92121 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"University of Ottawa Heart Institute, University of Ottawa , Ottawa, Ontario, K1N 6N5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P","family":"Liu","sequence":"additional","affiliation":[{"name":"University of Ottawa Heart Institute, University of Ottawa , Ottawa, Ontario, K1N 6N5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S","family":"Wilcox","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh","family":"Dang","sequence":"additional","affiliation":[{"name":"Thalheimer Center for Cardio-Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-8603","authenticated-orcid":false,"given":"Saro H","family":"Armenian","sequence":"additional","affiliation":[{"name":"Department of Population Sciences , City of Hope Comprehensive Cancer Center, Duarte, CA 91010 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Jain","sequence":"additional","affiliation":[{"name":"Sapient Bioanalytics LLC , San Diego, CA 92121 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Mangipudy","sequence":"additional","affiliation":[{"name":"Research and Development, Pfizer Inc , 1 Portland Street, Cambridge, MA 02139 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal S","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Research and Development, Pfizer Inc , 1 Portland Street, Cambridge, MA 02139 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2026091519575550500_ehag487-B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026091519575550500_ehag487-B2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jaccao.2024.06.005","article-title":"Cardiovascular considerations during cancer therapy: gaps in evidence and JACC: cardiooncology expert panel recommendations","volume":"6","author":"Leong","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jaccao.2020.08.010","article-title":"How to follow, manage and treat cardiac dysfunction in patients with Her2+ breast cancer","volume":"2","author":"Blaes","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaccao.2022.09.007","article-title":"Pharmacovigilance analysis of heart failure associated with anti-HER2 monotherapies and combination regimens for cancer","volume":"5","author":"Waliany","year":"2023","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jaccao.2022.06.002","article-title":"How to manage and monitor cardiac dysfunction in patients with metastatic HER2-positive breast cancer","volume":"4","author":"Dent","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jaccao.2024.07.008","article-title":"Life's essential 8 and incident cardiovascular disease in U.S. women with breast cancer","volume":"6","author":"Wadden","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jaccao.2023.10.008","article-title":"Impact of the ESC cardio-oncology guidelines biomarker criteria on incidence of cancer therapy-related cardiac dysfunction","volume":"6","author":"Mecinaj","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jaccao.2024.07.010","article-title":"Preventing cardiac damage in patients treated for breast cancer and lymphoma: the PROACT clinical trial","volume":"6","author":"Austin","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B9","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1161\/CIRCULATIONAHA.123.064274","article-title":"Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: the cardiac CARE trial","volume":"148","author":"Henriksen","year":"2023","journal-title":"Circulation"},{"key":"2026091519575550500_ehag487-B10","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1161\/CIR.0000000000001032","article-title":"Future perspectives of cardiovascular biomarker utilization in cancer survivors: a scientific statement from the American Heart Association","volume":"144","author":"Zaha","year":"2021","journal-title":"Circulation"},{"key":"2026091519575550500_ehag487-B11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jaccao.2020.07.006","article-title":"Primer on biomarker discovery in cardio-oncology: application of omics technologies","volume":"2","author":"Rhee","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40959-021-00092-0","article-title":"Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma","volume":"7","author":"M\u00f6rth","year":"2021","journal-title":"Cardio-Oncology"},{"key":"2026091519575550500_ehag487-B13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaccao.2024.10.004","article-title":"Serum proteins predict treatment-related cardiomyopathy among survivors of childhood cancer","volume":"7","author":"Poudel","year":"2025","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40959-025-00309-6","article-title":"Discovery of plasma proteins and metabolites associated with left ventricular cardiac dysfunction in pan-cancer patients","volume":"11","author":"Lal","year":"2025","journal-title":"Cardiooncology"},{"key":"2026091519575550500_ehag487-B15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12265-019-09897-y","article-title":"Changes in citric acid cycle and nucleoside metabolism are associated with anthracycline cardiotoxicity in patients with breast cancer","volume":"13","author":"Asnani","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"key":"2026091519575550500_ehag487-B16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12967-024-05088-9","article-title":"Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients","volume":"22","author":"Thonusin","year":"2024","journal-title":"J Transl Med"},{"key":"2026091519575550500_ehag487-B17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014708","article-title":"Changes in cardiovascular biomarkers with breast cancer therapy and associations with cardiac dysfunction","volume":"9","author":"Demissei","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026091519575550500_ehag487-B18","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.116.023463","article-title":"Detailed echocardiographic phenotyping in breast cancer patients: associations with ejection fraction decline, recovery, and heart failure symptoms over 3 years of follow-up","volume":"135","author":"Narayan","year":"2017","journal-title":"Circulation"},{"key":"2026091519575550500_ehag487-B19","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"2026091519575550500_ehag487-B20","doi-asserted-by":"publisher","first-page":"7680","DOI":"10.1038\/s41467-023-43485-8","article-title":"Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation","volume":"14","author":"M\u00e4larstig","year":"2023","journal-title":"Nat Commun"},{"key":"2026091519575550500_ehag487-B21","doi-asserted-by":"publisher","author":"Watrous","DOI":"10.1101\/2025.08.10.669154"},{"key":"2026091519575550500_ehag487-B22","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1021\/acs.analchem.6b04337","article-title":"Visualization, quantification, and alignment of spectral drift in population scale untargeted metabolomics data","volume":"89","author":"Watrous","year":"2017","journal-title":"Anal Chem"},{"key":"2026091519575550500_ehag487-B23","doi-asserted-by":"publisher","first-page":"12407","DOI":"10.1021\/acs.analchem.9b02983","article-title":"Deep neural networks for classification of LC-MS spectral peaks","volume":"91","author":"Kantz","year":"2019","journal-title":"Anal Chem"},{"key":"2026091519575550500_ehag487-B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026091519575550500_ehag487-B25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaccao.2025.01.012","article-title":"Cardiac effects of modern breast radiation therapy in patients receiving systemic cancer therapy","volume":"7","author":"Berlin","year":"2025","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.echo.2014.11.003","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"28","author":"Voigt","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026091519575550500_ehag487-B27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jcmg.2019.07.018","article-title":"Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy","volume":"13","author":"Upshaw","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026091519575550500_ehag487-B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cjs.10046","article-title":"Estimation methods for time-dependent AUC models with survival data","volume":"38","author":"Hung","year":"2010","journal-title":"Can J Stat"},{"key":"2026091519575550500_ehag487-B29","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"2026091519575550500_ehag487-B30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"2026091519575550500_ehag487-B31","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/sim.5647","article-title":"A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data","volume":"32","author":"Uno","year":"2013","journal-title":"Stat Med"},{"key":"2026091519575550500_ehag487-B32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaccao.2025.09.004","article-title":"Pretreatment circulating vascular biomarkers predict cancer therapy-related cardiac dysfunction during HER2(+) breast cancer treatment","volume":"7","author":"Gustafson","year":"2025","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/ATVBAHA.114.304292","article-title":"Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses","volume":"35","author":"Her\u00edas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026091519575550500_ehag487-B34","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6139732","article-title":"Cathepsin C is involved in macrophage M1 polarization via p38\/MAPK pathway in sudden cardiac death","volume":"2021","author":"Dai","year":"2021","journal-title":"Cardiovasc Ther"},{"key":"2026091519575550500_ehag487-B35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1186\/s12967-023-04659-6","article-title":"Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats","volume":"21","author":"Liu","year":"2023","journal-title":"J Transl Med"},{"key":"2026091519575550500_ehag487-B36","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1038\/s41467-024-50747-6","article-title":"Cathepsin C inhibition reduces neutrophil serine protease activity and improves activated neutrophil-mediated disorders","volume":"15","author":"Nishibata","year":"2024","journal-title":"Nat Commun"},{"key":"2026091519575550500_ehag487-B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117308","article-title":"Human vascular smooth muscle cells utilise chymase for the atypical cleavage and activation of Interleukin-1\u03b2","volume":"390","author":"Morales-Maldonado","year":"2024","journal-title":"Atherosclerosis"},{"key":"2026091519575550500_ehag487-B38","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/ejhf.1674","article-title":"The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach","volume":"22","author":"Hoes","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026091519575550500_ehag487-B39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","article-title":"Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials","volume":"15","author":"Liu","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2026091519575550500_ehag487-B40","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCRESAHA.116.309004","article-title":"Baseline immunoglobulin E levels as a marker of doxorubicin- and trastuzumab-associated cardiac dysfunction","volume":"119","author":"Beer","year":"2016","journal-title":"Circ Res"},{"key":"2026091519575550500_ehag487-B41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.18632\/aging.101760","article-title":"S100a13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1\u03b1","volume":"11","author":"Su","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"2026091519575550500_ehag487-B42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41525-021-00174-z","article-title":"Convergence of biomarkers and risk factor trait loci of coronary artery disease at 3p21.31 and HLA region","volume":"6","author":"Nikpay","year":"2021","journal-title":"NPJ Genom Med"},{"key":"2026091519575550500_ehag487-B43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s42256-024-00801-1","article-title":"Unsupervised ensemble-based phenotyping enhances discoverability of genes related to left-ventricular morphology","volume":"6","author":"Bonazzola","year":"2024","journal-title":"Nat Mach Intell"},{"key":"2026091519575550500_ehag487-B44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jaccao.2024.10.010","article-title":"Shared mechanisms in cancer and cardiovascular disease: S100A8\/9 and the NLRP3 inflammasome: JACC: CardioOncology state-of-the-art review","volume":"7","author":"Van Linthout","year":"2025","journal-title":"JACC CardioOncol"},{"key":"2026091519575550500_ehag487-B45","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.121.058411","article-title":"Proteasomal degradation of TRAF2 mediates mitochondrial dysfunction in doxorubicin-cardiomyopathy","volume":"146","author":"Dhingra","year":"2022","journal-title":"Circulation"},{"key":"2026091519575550500_ehag487-B46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98278","article-title":"TNF receptor-activated factor 2 mediates cardiac protection through noncanonical NF-\u03baB signaling","volume":"3","author":"Evans","year":"2018","journal-title":"JCI Insight"},{"key":"2026091519575550500_ehag487-B47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamacardio.2023.4994","article-title":"Genetic associations of circulating cardiovascular proteins with gestational hypertension and preeclampsia","volume":"9","author":"Schuermans","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026091519575550500_ehag487-B48","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1093\/eurheartj\/ehad262","article-title":"Cationic proteins from eosinophils bind bone morphogenetic protein receptors promoting vascular calcification and atherogenesis","volume":"44","author":"Meng","year":"2023","journal-title":"Eur Heart J"},{"key":"2026091519575550500_ehag487-B49","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1080\/21655979.2021.1918522","article-title":"Fus knockdown inhibits the profibrogenic effect of cardiac fibroblasts induced by angiotensin II through targeting Pax3 thereby regulating TGF-\u03b21\/Smad pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"2026091519575550500_ehag487-B50","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1038\/s41467-019-11777-7","article-title":"Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS\/VEGF-A axis","volume":"10","author":"Garikipati","year":"2019","journal-title":"Nat Commun"},{"key":"2026091519575550500_ehag487-B51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11306-025-02258-8","article-title":"A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity","volume":"21","author":"Singh","year":"2025","journal-title":"Metabolomics"},{"key":"2026091519575550500_ehag487-B52","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/CIRCRESAHA.119.315483","article-title":"Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis","volume":"126","author":"Ritterhoff","year":"2020","journal-title":"Circ Res"},{"key":"2026091519575550500_ehag487-B53","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ Toxicol Chem"},{"key":"2026091519575550500_ehag487-B54","doi-asserted-by":"publisher","first-page":"56001","DOI":"10.1289\/EHP11840","article-title":"Associations between per- and polyfluoroalkyl substances exposures and blood lipid levels among adults\u2014a meta-analysis","volume":"131","author":"Liu","year":"2023","journal-title":"Environ Health Perspect"},{"key":"2026091519575550500_ehag487-B55","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/toxsci\/kfae065","article-title":"PFAS and their association with the increased risk of cardiovascular disease in postmenopausal women","volume":"200","author":"Arredondo Eve","year":"2024","journal-title":"Toxicol Sci"},{"key":"2026091519575550500_ehag487-B56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12940-024-01147-2","article-title":"Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women","volume":"23","author":"Zhu","year":"2024","journal-title":"Environ Health"},{"key":"2026091519575550500_ehag487-B57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12940-024-01074-2","article-title":"All-cause, cardiovascular disease and cancer mortality in the population of a large Italian area contaminated by perfluoroalkyl and polyfluoroalkyl substances (1980-2018)","volume":"23","author":"Biggeri","year":"2024","journal-title":"Environ Health"},{"key":"2026091519575550500_ehag487-B58","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1161\/CIRCRESAHA.124.323697","article-title":"Perfluoroalkyl\/Polyfluoroalkyl substances: links to cardiovascular disease risk","volume":"134","author":"Schlezinger","year":"2024","journal-title":"Circ Res"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/35\/5010\/68642130\/ehag487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/35\/5010\/68642130\/ehag487.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:58:06Z","timestamp":1789516686000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/35\/5010\/8721350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":58,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2026,6,29]]},"published-print":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag487","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,14]]},"published":{"date-parts":[[2026,6,29]]}}}